As well as looking for treatements/cures for systemic body odors, one of the interests of
MEBO Research is to seek ways that people can monitor their condition frequently in a simple manner. An obvious answer for this in relation to TMAU would be a handheld electronic device that has a sensor to read trimethylamine measurements. These are already commonly used for diabetes self-management, such as the
accu-chek series of devices by Hoffman-Roche.
An interesting variation of such a device for testing for sexually transmitted infections is being developed, which will be an application for mobile phones, and the testing strips will cost around $1. Like the diabetes testers, this will likely rely on testing for levels of certain biomarkers. The
eSTI is being developed in the UK.
It is likely that a device for monitoring trimethylamine levels could be easily developed and manufactured already. The difficulty is probably convincing a company that there would be a market for such a device. It is interesting to note that the diabetes electronic monitors often retail for less than $50.
0 comments: